Abstract
This chapter discusses the regulatory provisions to be adhered by a firm entering into an M&A deal, which is majorly governed by but not limited to Companies Act 2013 and SEBI Takeover Regulations, 2011. As per Companies Act 2013, a new regulatory entity National Company Law Tribunal (NCLT) has been established for handling the M&A cases. The provisions of Companies Act are also explained through real-life case of Sun Pharma and Ranbaxy scheme of Amalgamation to help readers understand the regulatory aspects of M&A. The SEBI Takeover Regulations framework has been explained in detail to explain the meaning and role of various parties related to M&A, provisions related to triggering of open offer and disclosure requirements. The pricing of open offer based on SEBI prescribed methods has been explained with the help of numerical examples.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Appendices
Annexure I
Annexure II
Rights and permissions
Copyright information
© 2019 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumar, V., Sharma, P. (2019). Regulatory Insights for M&A in India. In: An Insight into Mergers and Acquisitions. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-13-5829-6_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-5829-6_8
Published:
Publisher Name: Palgrave Macmillan, Singapore
Print ISBN: 978-981-13-5828-9
Online ISBN: 978-981-13-5829-6
eBook Packages: Business and ManagementBusiness and Management (R0)